F-18 Fluorodeoxyglucose (FDG) Negative Hepatoblastoma with High Alphaphetoprotein Levels; Better Prognosis
Journal: Journal of Pediatric Disorders and Neonatal Care (Vol.1, No. 1)Publication Date: 2018-06-20
Authors : Koç ZP; Kara PO; Çıtak EC; Esen K;
Page : 1-3
Keywords : Hepatoblastoma; Fluorodeoxyglucose; Positron Emission Tomography; Alphaphetoprotein;
- F-18 Fluorodeoxyglucose (FDG) Negative Hepatoblastoma with High Alphaphetoprotein Levels; Better Prognosis
- BRCA1 Mutation Leads to Deregulated Ubc9 Levels which Triggers Proliferation and Migration of Patient-Derived High Grade Serous Ovarian Cancer and Triple Negative Breast Cancer Cells
- Can Prealbumin, Albumin and CRP Levels be used to Predict Prognosis in Patients with Gastric Cancer
- Implication of Plasma miR 122 and miR 151-3p Levels in Diagnosis and Prognosis of Acute Coronary Syndrome Patients
- Basal-Like Subgroup is Associated with Younger Age, Increased Expression of Androgen Receptor, and Worse Prognosis, while Non-basal-like Subtype is Associated with Higher BMI in Triple-Negative Breast Cancer Patients
Abstract
Although hepatoblastoma is the most common malign tumor in childhood in the liver there are few studies including fluorodeoxyglucose positron emission tomography/computed tomography imaging and hepatoblastoma. The patient included in this report has multiple hepatic lesions with high alphaphetoprotein (AFP) levels suggestive of hepatoblastoma but no increased FDG uptake in the liver lesions who responded the chemotherapy very well.
Other Latest Articles
- Does the Opening of a Milk Bank in NICU Cancel the Incidence of NEC?
- A Case Report on Neonatal Hepatoblastoma
- Diagnosis of the Bone Age and Prediction of Adult Height by the Ebrí Methods (New Computer Programs): New Software, Bone Age Calculation
- Court Obstetric – Pediatric Issues: Evidence-Based Practice
- Trends in Human Immunodeficiency Virus Type 1/2 Prevalence among Young Adult Blood Donors, from 2011 to 2016, Attending a Private Clinic in Angola. Retrospective Study of Prevalence
Last modified: 2018-12-05 22:02:27